Double-Blinded Trial Syrup for Hypertension Study from China
A flavored syrup placebo in single-dose vials for oral administration in double-blinded hypertension drug trials, matching the active comparator's viscosity and color. Classified under HTS 3006.93.60.00 for blinded clinical trial kits in liquid form per Note 6(e).
Duty Rate — China → United States
25%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include blinded protocol from IRB-approved trial demonstrating measured doses for oral intake to differentiate from general syrups
• Ensure cold-chain documentation if refrigerated, as customs may inspect for pharmaceutical waste under Note 6(k)
• Avoid retail packaging; use institutional labeling to prevent reclassification as consumer beverage